Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.56 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.48 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSPO | P30536 | 1/20 | 0.46 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3410348 | 1.00 | ENPP2 (0.56) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL1295800 | 0.99 | ENPP2 (0.57) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL1295557 | 0.99 | ENPP2 (0.57) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL2947211 | 0.91 | ENPP2 (0.69) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL234818 | 0.91 | ENPP2 (0.69) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL30553865 | 0.91 | ENPP2 (0.60) | ENPP2LPAR1LPAR3SMN1; SMN2S1PR1 | |
| SCHEMBL7057551 | 0.91 | PRKCA (0.47) | ALDH1A1 | |
| SCHEMBL7057555 | 0.91 | PRKCA (0.47) | ALDH1A1 | |
| SCHEMBL9641266 | 0.91 | PRKCA (0.47) | ALDH1A1 | |
| SCHEMBL9641260 | 0.91 | PRKCA (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240844-B | Herpes zoster mRNA vaccine and preparation method and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118480560-B | Respiratory syncytial virus mRNA vaccine and preparation method and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118240844-A | Herpes zoster mRNA vaccine and preparation method and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118125947-A | Low-toxicity spleen-targeted cationic lipid compound containing carbamate structure, composition containing low-toxicity spleen-targeted cationic lipid compound and application of low-toxicity spleen-targeted cationic lipid compound | 北京悦康科创医药科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117534719-B | C6' substituted lock nucleic acid modified capping analogue and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117229160-B | Triester cationic lipid compounds, compositions containing same and uses thereof | 北京悦康科创医药科技股份有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-116535381-B | Cationic lipid compound having five-membered ring acetal structure, composition containing same and use | 北京悦康科创医药科技股份有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-116375592-A | Novel long-acting low-toxicity cationic lipid compounds and compositions thereof | 北京悦康科创医药科技股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-114957027-B | Cationic lipid compound, composition containing cationic lipid compound and application of cationic lipid compound | 北京悦康科创医药科技股份有限公司 | 2023-05-19 | — | — | CN | claimed |
| CN-122094668-A | Preparation method and application of lipid nanoparticle | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122055140-A | Pharmaceutical composition containing nucleic acid construct and medical application thereof | 上海瑞宏迪医药有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-117925729-B | Transfection reagent based on blank lipid nano-particles, preparation method and application thereof | 晟迪生物医药(苏州)有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120092088-A | Artificial nucleic acid molecules | 斯微(上海)生物科技股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120076798-A | Lipid composition | 斯微(上海)生物科技股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2012088414-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2012-06-28 | — | — | WO | disclosed |
| US-20120003159-A1 | COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-01-05 | — | — | US | disclosed |
| WO-2010126319-A2 | LIPOPEPTIDE WITH SPECIFIC AFFINITY TO THE FC REGION OF AN ANTIBODY, AND ANTIGEN-RECOGNIZING LIPID NANOPARTICLE COMPRISING SAME | 고려대학교 산학협력단 (KR) | 2010-11-04 | — | — | WO | disclosed |
| US-7785568-B2 | Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography | MARVAL BIOSCIENCES, INC. (US) | 2010-08-31 | — | — | US | disclosed |
| US-20080131369-A1 | Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography | MARVEL THERAPEUTICS (US) | 2008-06-05 | — | — | US | disclosed |
| US-20070212303-A1 | Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography | MARVAL PHARMA, INC. | 2007-09-13 | — | — | US | disclosed |